跳至主要内容
临床试验/NCT02311829
NCT02311829Unknown不适用

Evaluation d'un Dispositif de Suivi téléphonique Sur la Qualité de Vie Dans Les Crises Psychogènes Non Epileptiques.

Central Hospital, Nancy, France8 个研究点 分布在 1 个国家目标入组 136 人开始时间: 2014年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
136
试验地点
8
主要终点
Evolution of quality of life scores every 6 months (From 6 to 24 months)

研究概览

简要总结

The goal of this study is to evaluate effectiveness of the phone follow-up method compared to the conventional filler taken one.

详细描述

This study is a multicenter, non-drug therapy and randomized research trial, comparing a group of patients integrating the phone monitoring device (DST group) to a control group where patients are cared for in the usual way.

Subject recruiting modalities:

The study population represents patients diagnosis, PNES confirmed by following by the video-EEG, recorded in a center of epilepsy and in different CHU and informed of the diagnosis of PNES in a standardized manner.

Patients were recruited during their hospitalization video-EEG is conducted in part of the diagnostic workup of drug-resistant epilepsies, or demonstrations paroxysmal undetermined which may prove to be PNES.

Usual care:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient above 18 years old
  • Affiliation to social security
  • Evolution disorders for over three months with at least 3 psychogenic non-epileptic seizures spaced over 24 hours and less than two years
  • Diagnosis of PNES (associated or not with epilepsy) or laid confirmed following a video-EEG examination
  • Standardized announcement of the disease made by a neurologist participant / PHRC training
  • Good understanding of the French language
  • Patient consented to participate in the study

排除标准

  • Acute psychiatric pathology at the time of inclusion warranting urgent hospitalization (acute suicidal risk, Table delusional ...)
  • Progressive neurological pathology intercurrent susceptible to aggravation for the duration of the study (glioma, multiple sclerosis, dementia ...)
  • A patient who can not physically comply with the six-monthly review at the discretion of the investigator (planned move ...)
  • Simultaneous participation to another therapeutic intervention study during the first 12 months

结局指标

主要结局

Evolution of quality of life scores every 6 months (From 6 to 24 months)

时间窗: 24 months

The primary endpoint is the assessment of quality of life scores measured at 6, 12, 18 and 24 months after start of treatment (visit D0) by self-administered questionnaires of quality of life (SF-36 general questionnaire quality of life) and QOLIE 31 (specific questionnaire epilepsy).

次要结局

  • Severity of seizures(24 months)
  • Number of urgent consultations or unprogrammed and \ or unprogrammed(24 months)
  • Frequency of non epileptic seizures per month(24 months (average for 6 months))
  • Psychiatric symptomology scores(24 months)
  • Percentage of programmed psychological consultation and actually honored in medical and psychological center(24 months)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验